Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. (HKSE: 9960) is trading at HK$0.95, about ₹12 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, up 1.60% today. Indian residents can buy Kindstar Globalgene Technology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.92
Today's high
HK$0.95
52 week low
HK$0.90
52 week high
HK$1.56
9960 opened at HK$0.94, closed previously at HK$0.94, and has traded between HK$0.90 and HK$1.56 over the past 52 weeks.
About
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research, clinical drug trials, and translational medicine initiatives for a diverse client base, including individual practitioners, research organizations, various hospital types, and pharmaceutical firms. This broad service portfolio is underpinned by its extensive, state-of-the-art laboratory infrastructure, which encompasses disciplines such as flow cytometry, cytogenetics, medical genomics, molecular biology, hematopathology, mass spectrometry, pathology, clinical immunology, and microbiology, alongside dedicated scientific research labs. Kindstar Global offers a comprehensive range of diagnostic tests covering key areas like hematology (blood), oncology (tumor), and genetic disorders. Its capabilities also extend to diseases affecting the cardiovascular and cerebrovascular systems, infectious agents, and autoimmune conditions, supporting various medical specialties including internal medicine, surgery, gynecology, pediatrics, and numerous other clinical fields. Established in 2003, the company maintains its headquarters in Wuhan, China.
Key statistics
Avg. volume
425.56K
Market cap
HK$981.64M
P/E Ratio
-19.85
Price-to-sales ratio
0.88
Enterprise value
CN¥612.08M
Free cash flow yield
16.50%
Debt-to-equity ratio
0.15
Return on equity
-1.56%
ROIC
-2.98%
Beta
0.64
Dividend yield
10.00%
Last dividend
HK$0.10
Financial overview
Revenue
CN¥933.57M
Earnings per share
-CN¥0.06
Free cash flow
CN¥43.60M
Net profit margin
-4.37%
Gross margin
45.55%
EBITDA
-CN¥95.69M
Revenue growth
0.65%
Similar securities
This is not an investment recommendation
How to buy Kindstar Globalgene Technology from India
Indian residents can buy Kindstar Globalgene Technology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Kindstar Globalgene Technology and place an order
Find Kindstar Globalgene Technology by name or by its ticker, 9960, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Kindstar Globalgene Technology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kindstar Globalgene Technology position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Kindstar Globalgene Technology from India
Trading and taxes when buying Kindstar Globalgene Technology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Kindstar Globalgene Technology’s current yield is 10.00%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Kindstar Globalgene Technology stock?
Yes. Kindstar Globalgene Technology (9960) has been listed on the Hong Kong Stock Exchange since 2021, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Kindstar Globalgene Technology share cost in rupees?
One Kindstar Globalgene Technology share is HK$0.95 — about ₹12 at an HKD/INR rate of 12.23 on 26 Sep 2026. Both the Kindstar Globalgene Technology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kindstar Globalgene Technology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Kindstar Globalgene Technology?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Kindstar Globalgene Technology shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kindstar Globalgene Technology price. Paasa issues a capital-gains statement for your return.
Does Kindstar Globalgene Technology pay a dividend, and how is it taxed in India?
Yes. Kindstar Globalgene Technology pays a dividend and the current yield is 10.00%; the last declared dividend was HK$0.10 per share, about ₹1.16. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Kindstar Globalgene Technology from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Kindstar Globalgene Technology a Hong Kong SAR China company, and does that change how it is taxed?
Kindstar Globalgene Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Kindstar Globalgene Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Kindstar Globalgene Technology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kindstar Globalgene Technology holding, its cost and its closing value.
How do I sell Kindstar Globalgene Technology and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.